MARSHALL WACE, LLP - PLIANT THERAPEUTICS INC ownership

PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 139 filers reported holding PLIANT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 1.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of PLIANT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,281,791
+29.0%
73,921
+97.9%
0.00%
+50.0%
Q1 2023$993,616
-21.9%
37,354
-43.2%
0.00%
-33.3%
Q4 2022$1,272,300
+242.9%
65,820
+41.8%
0.00%
+200.0%
Q2 2022$371,00046,4140.00%
Other shareholders
PLIANT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TRV GP III, LLC 339,160$5,881,034100.00%
CHI Advisors LLC 3,014,199$52,266,21120.72%
TRV GP IV, LLC 2,132,867$36,983,91413.93%
GREAT POINT PARTNERS LLC 1,755,184$30,434,8915.54%
First Light Asset Management, LLC 2,933,260$50,862,7284.83%
Deep Track Capital, LP 5,500,000$95,370,0003.68%
Casdin Capital, LLC 1,577,108$27,347,0533.03%
Fernwood Investment Management, LLC 379,702$6,584,0332.37%
Redmile Group, LLC 2,678,099$46,438,2372.21%
SILVERARC CAPITAL MANAGEMENT, LLC 250,409$4,342,0921.32%
View complete list of PLIANT THERAPEUTICS INC shareholders